Alchemab Therapeutics
Alchemab Therapeutics
alchemab.com
Locations
England, UK · London, UK · Mile End, London, UK · Kingston Vale, London SW15, UK
industry
Biotechnology · Biotechnology Research · Medical · Pharmaceutical
Size
11 - 50 employees
Stage
Series A
founded in
2019
Socials
LinkedInCrunchbaseTwitter
About

Alchemab Therapeutics is developing natural protective antibodies designed to keep people free of hard-to-treat diseases. The company is building their transformative engine to identify drug targets and develop a pipeline of antibody therapeutics for hard-to-treat cancers, neurodegenerative conditions, and infectious diseases. Alchemab Therapeutics was established in 2019 by Uri Laserson and Jane Osbourn in London, England.

Something looks off?
Open jobs at Alchemab Therapeutics

On-site & Remote

Powered by Getro